In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Science and ...
Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death (SCD), and ...
Morning Overview on MSN
New AI navigation lets drones fly without GPS or cameras, researchers say
A peer-reviewed study published in Satellite Navigation describes an AI framework that can estimate a drone’s position, ...
Two research teams mined genomic data from bacteria to create databases containing thousands of antiviral defence proteins ...
UNION BRIDGE, MD, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- Veteran Clinical Research Executive and Consultant ...
A recent study explored rapid evaporative ionization mass spectrometry (REIMS) as a high-throughput, real-time alternative. By analyzing metabolomic fingerprints from pig neck fat, REIMS was combined ...
Opinion
The real US surveillance threat isn’t AI — it’s the data infrastructure we already built
The FBI doesn't need AI to conduct mass surveillance — it just needs access to the commercial data infrastructure that already blankets everyday life. The Guardian's report reveals that the real ...
Deep learning has been successfully applied in the field of medical diagnosis, and improving the accurate classification of ...
Researchers have optimized a headspace sorptive extraction (HSSE) method coupled with gas chromatography-mass spectrometry ...
Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a significant obstacle in transferring research datasets to actual clinical settings.
A recent INMA Webinar featured Erica Greene, director of engineering for machine learning at Yahoo News, and Ritvvij Parrikh, senior director of product management/AI at Times Internet, who shared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results